MapLight Therapeutics reported net income of -$60.25M for the quarter ended Jun 2026. This income statement covers 6 quarters of results from Sep 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Sep2024 | Dec2024 | Jun2025 | Sep2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 0.76M | 0.76M | 0.79M | 0.79M | 8.68M | 45.44M |
| Operating items | ||||||
| Research & DevelopmentR&D | 16.81M | 20.71M | 26.85M | 27.09M | 64.62M | 53.44M |
| Selling, General & AdministrativeSG&A | 4.08M | 2.06M | 3.82M | 4.40M | 18.75M | 10.11M |
| Operating ExpensesOpex | 20.89M | 22.78M | 30.66M | 31.50M | 83.38M | 63.55M |
| Operating IncomeOp. Inc | -20.89M | -22.78M | -30.66M | -31.50M | -83.38M | -63.55M |
| EBIT | -20.89M | -22.78M | -30.66M | -31.50M | -83.38M | -63.55M |
| Non-operating items | ||||||
| Interest & Investment IncomeInt & Inv Inc | 1.08M | 0.90M | 0.69M | 1.55M | 2.47M | 2.35M |
| Other Non Operating IncomeOther Non Op Inc. | 0.80M | 0.65M | 0.13M | 0.53M | 1.36M | 1.01M |
| Non Operating IncomeNon Op. Inc. | 1.88M | 1.55M | 2.08M | 3.83M | ||
| Net income details | ||||||
| EBT | -19.81M | -21.88M | -29.98M | -29.95M | -80.91M | -61.20M |
| Profit After TaxPAT | -19.02M | -21.23M | -29.88M | -29.42M | -79.82M | -60.25M |
| Income from Continuing OperationsIncome (Continuing) | -19.81M | -21.88M | -29.98M | -29.95M | -80.91M | -61.20M |
| Consolidated Net IncomeConsol Net Inc. | -19.81M | -21.88M | -29.98M | -29.95M | -80.91M | -61.20M |
| Income towards Parent CompanyParent Net Inc | -19.81M | -21.88M | -29.98M | -29.95M | -80.91M | -61.20M |
| Net Income towards Common StockholdersNet Income | -19.81M | -21.88M | -29.98M | -29.95M | -80.91M | -61.20M |
| Additional items | ||||||
| EPS (Basic) | -26.13 | -29.72 | -39.28 | -37.86 | -9.32 | -1.35 |
| EPS (Diluted) | -26.13 | -29.72 | -39.28 | -37.86 | -9.32 | -1.35 |
| Shares Outstanding | 0.76M | 0.74M | 0.76M | 0.79M | 8.68M | 45.43M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 0.76M | 0.74M | 0.76M | 0.79M | 8.68M | 45.43M |
| EBITDA | -20.89M | -22.78M | -30.66M | -31.50M | -83.38M | -63.55M |